ABVC BioPharma Inc. (ABVC): Total Asset Value of Company

ABVC BioPharma brings together biochemists developing plant-based treatments for tumors and psychiatric disorders within an atmosphere of creative freedom. The company's production capacities include state-of-the-art extraction laboratories where equipment is maintained in pristine condition. The price action of the securities based on total assets, which stands at 17.83, is available below. The business capitalization relies on partnerships with clinics and payments under licensing contracts.

ABVC BioPharma (ABVC) Company Total Assets: for the period 07/04/2022 - 10/26/2026

Comprehensive metric breakdowns and analytics for ABVC BioPharma Inc (ABVC)

- price and consensus price forecast:

Stock Quotes abvcpharma.com|ABVC - Price Target Chart

- market capitalization data:

Market Valuation ABVC BioPharma, Inc|ABVC - Enterprise Value

- book capitalization data:

Accounting Value of a Share ABVC BioPharma|ABVC - Book Capitalization|Market Capitalization to Book Value Ratio abvcpharma.com|ABVC - Aggregate Company Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio ABVC BioPharma|ABVC - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio ABVC BioPharma, Inc|ABVC - Company Aggregate Debts|Debts to Book Capitalization ABVC BioPharma, Inc

Fundamental valuation:ABVC, abvcpharma.com

The metric is calculated inversely via return on assets (ROA), combining equity and liabilities to assess the company's overall resource potential. The trend in total assets reflects the scale of ABVC BioPharma investments in the development of plant-based drugs for oncology and psychiatry, allowing investors to correlate the growth of the asset base with the efficiency of clinical trials and the search for strategic partners.

Competitors of ABVC BioPharma (ABVC)

HLN (haleon.com) - Cumulative Company Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value oramed.com (ORMP)|Company Total Assets ENTX (Entera Bio)|Company Total Assets MindWalk Holdings, Inc. HYFT|CPIX - Company Total Assets|Quantum BioPharma Corp (QNTM) - Aggregate Company Assets|FibroGen, Inc. (FGEN) - Cumulative Company Assets|telomirpharma.com (TELO) - Aggregate Company Assets|Company Total Assets RANI|Cumulative Company Assets Synergy CHC Corporation (SNYR)|Rallybio Corporation (RLYB) - Cumulative Company Assets|Aggregate Asset Value lexariabioscience.com (LEXX)|Company Total Assets Pulmatrix, Inc. PULM|Aggregate Company Assets Pheton Holdings Limited PTHL|Company Total Assets APM (Aptorum)|LYRA: Company Total Asset Base|Aggregate Company Assets IBO|TNFA (TNF Pharmaceuticals, Inc.) - Company Assets|Aggregate Company Assets cbdMD Inc. YCBD|Total Asset Value of Company painreform.com|Altamira Therapeutics (CYTO) - Company Total Assets|Aggregate Asset Value Lipella Pharmaceuticals Inc (LIPO)|Company Total Assets OPTN (Optinose)|Pieris Pharma - Company Total Assets|Aggregate Company Assets Procaps Group S.A. (PROC)|PTPI: Aggregate Asset Value|QLI (Qilian International Holding) - Aggregate Company Assets|Acelyrin Inc. (SLRN) - Cumulative Company Assets|TFFP (TFF Pharma) - Company Total Assets